XML 17 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Statements of Operations [Abstract]        
REVENUES $ 18,366 $ 22,749
OPERATING EXPENSES        
Cost of revenues 3,530
Advertising 9,157 36,365
Payroll and related expense 93,155 170,941 175,891 342,260
Stock-based compensation 187,200
Amortization of software costs 12,850 25,700
Allowance for uncollectible advances to COWA Science Corporation ("COWA") 203,000 203,000
Other general and administrative expenses 183,636 397,056 312,228 963,447
TOTAL OPERATING EXPENSES 276,791 793,004 488,119 1,761,502
LOSS FROM OPERATIONS (276,791) (774,638) (488,119) (1,738,753)
OTHER INCOME (EXPENSE)        
Interest expense (1,063,357) (351,391) (2,005,006) (590,178)
Derivative liability for authorized shares shortfall (78,849,723) (109,978,818)
Change in fair value of derivative liabilities 61,818 (32,899) 388,880 (32,899)
Impairment on investment (65,000)   (65,000)
Gain (loss) on conversion of convertible notes (1,232) (132,480) 882 (426,077)
TOTAL OTHER INCOME (EXPENSE) (79,852,494) (581,770) (111,594,062) (1,114,154)
Net Loss Before Income Taxes (80,129,285) (1,356,408) (112,082,181) (2,852,907)
Provision for income taxes (benefit)
NET LOSS (80,129,285) (1,356,408) (112,082,181) (2,852,907)
Deemed dividend from warrant price protection   (3,808,742) (95,002,933) (3,808,742)
Deemed dividend related to warrants issued in Series B Preferred Stock offering   (63,784)   (63,784)
Deemed dividend for issuance of common shares to settle warrant provision   (437,400)   (437,400)
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS $ (80,129,285) $ (5,666,334) $ (207,085,114) $ (7,162,833)
Net loss per common share-basic and diluted $ (0.06) $ (0.03) $ (0.15) $ (0.04)
Weighted average common shares outstanding-basic and diluted 1,392,572,373 188,703,582 1,380,529,231 183,359,622